Gilead Sciences. has been granted a patent for compounds of Formula (I), with specific substituents defined in the documentation. The patent includes a claim for the compound itself, indicating its potential applications in various fields. GlobalData’s report on Gilead Sciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Gilead Sciences, Peptide pharmacophores was a key innovation area identified from patents. Gilead Sciences's grant share as of June 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US12037340B2 outlines specific claims related to novel chemical compounds, particularly focusing on a compound represented by a defined formula (I). The claims detail variations of this compound, including specific substituents such as chloro (R1) and structural components (V1a and V1b). These variations suggest a range of potential chemical entities that may possess unique properties or applications in various fields, including pharmaceuticals.
Additionally, the patent claims encompass a pharmaceutical composition that includes the aforementioned compounds or their pharmaceutically acceptable salts, stereoisomers, or mixtures thereof. This composition is formulated with at least one pharmaceutically acceptable excipient, indicating its potential use in therapeutic applications. The specificity of the claims highlights the innovative aspects of the compounds and their formulations, which may contribute to advancements in drug development and delivery systems.
To know more about GlobalData’s detailed insights on Gilead Sciences, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
